How does mSMART stratify risk in myeloma and help guide with treatment decisions ? скачать в хорошем качестве

How does mSMART stratify risk in myeloma and help guide with treatment decisions ?

mSMART (Mayo Stratification of Myeloma and Risk-Adapted Therapy) is a clinical tool developed by Mayo Clinic to guide treatment decisions in multiple myeloma. It helps doctors identify whether a patient's disease is standard-, intermediate-, or high-risk—based on genetic abnormalities, lab values, and clinical features. In this video, we break down how mSMART works, what specific biomarkers it uses (like t(4;14), del(17p), and others), and how these risk levels impact therapy choices. Understanding your risk category can help personalize treatment and give deeper insight into prognosis Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer! Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_so... Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.